Jinan, China

Fei Tang

This inventor holds 1 USPTO granted patent. Top assignee: Qilu Antibiotics Pharmaceutical Co. Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Tang. Retrieved from https://idiyas.com/inventor/fei-tang-3tkt2862

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fei Tang: Innovator in Cephalosporin Intermediate Production

Introduction

Fei Tang is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin intermediates. His work has implications for industrial production and the pharmaceutical industry.

Latest Patents

Fei Tang holds a patent for the "Crystal of cephalosporin intermediate 7α-methoxy cephalothin and method for preparing same." This invention relates to a crystal of 7α-methoxy cephalothin, which is characterized by its high purity and stability. The preparation method is simple, cost-effective, and can be easily controlled, making it suitable for industrial applications.

Career Highlights

Fei Tang is associated with Qilu Antibiotics Pharmaceutical Co. Ltd., where he has been instrumental in advancing pharmaceutical innovations. His expertise in cephalosporin intermediates has positioned him as a key figure in the industry.

Collaborations

Fei Tang has worked alongside notable colleagues such as Xin Wang and Jinglong Fu. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical sector.

Conclusion

Fei Tang's innovative work in the field of cephalosporin intermediates showcases his commitment to advancing pharmaceutical science. His contributions are vital for the development of effective and stable pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…